Arkolith/Insider Trading/DYN/Form 4

Kersten Dirk

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Apr 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$219K
Net Open-Market Flow
-$219K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Sell(S)3K$20.00$53K4.2M
Apr 21, 2026Sell(S)8K$20.01$166K4.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-173736) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML